NDC 69097-168

arformoterol tartrate

Arformoterol Tartrate

arformoterol tartrate is a Respiratory (inhalation) Solution in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Arformoterol Tartrate.

Product ID69097-168_2778338e-3637-4d86-9876-0d86d68c239c
NDC69097-168
Product TypeHuman Prescription Drug
Proprietary Namearformoterol tartrate
Generic NameArformoterol Tartrate
Dosage FormSolution
Route of AdministrationRESPIRATORY (INHALATION)
Marketing Start Date2021-06-22
Marketing CategoryANDA /
Application NumberANDA207306
Labeler NameCipla USA Inc.
Substance NameARFORMOTEROL TARTRATE
Active Ingredient Strength15 ug/2mL
Pharm ClassesAdrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 69097-168-64

12 POUCH in 1 CARTON (69097-168-64) > 5 VIAL, SINGLE-DOSE in 1 POUCH > 2 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2021-06-22
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "arformoterol tartrate" or generic name "Arformoterol Tartrate"

NDCBrand NameGeneric Name
0093-5955Arformoterol tartrateArformoterol tartrate
62332-633Arformoterol tartrateArformoterol tartrate
62756-277Arformoterol TartrateArformoterol Tartrate
68462-833ARFORMOTEROL TARTRATEarformoterol tartrate
69097-168arformoterol tartratearformoterol tartrate
70748-175Arformoterol tartrateArformoterol tartrate
70748-257Arformoterol TartrateArformoterol Tartrate
70756-612arformoterol tartratearformoterol tartrate
63402-911Brovanaarformoterol tartrate
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.